Valiant Laboratories’ Rs 152.4 crore IPO will open for subscription on September 27. The offer consists of only a fresh issue of 1.09 crore shares. The paracetamol manufacturer will use the proceeds to set up a manufacturing facility for speciality chemicals in Gujarat and fund its subsidiary VASPL’s working capital requirements.